CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MOHEDD project focuses on developing advanced drug delivery systems for glioblastoma treatment by integrating nano metal-organic frameworks with hydrogels. This innovative approach aims to enhance the efficiency of drug delivery, ultimately facilitating faster market access for effective therapies against this aggr…
The treatment of glioblastoma – the most common, aggressive and lethal type of brain cancer with survival rated below 14% – requires novel and improved drug delivery systems to overcome the drawback of state-of-the-art local chemotherapy by using Gliadel wafers.
MOHEDD aims to evaluate the feasibility of advanced nanoMOFs and hydrogel hybrids for controlled drug delivery into the commercial stage, with the idea of accelerating their access to the market as highly efficient delivery vehicles for…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
